ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
the Zig
|
115 |
33K |
6 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
115
|
33K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
the Zig
|
115 |
33K |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
115
|
33K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Let’s go
|
|
the Zig
|
92 |
36K |
1 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
92
|
36K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Let’s go
|
|
the Zig
|
92 |
36K |
6 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
92
|
36K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Let’s go
|
|
the Zig
|
92 |
36K |
5 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
92
|
36K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Let’s go
|
|
the Zig
|
92 |
36K |
0 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
92
|
36K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Wilsons report - 30c 12 month target
|
|
the Zig
|
5 |
2.7K |
2 |
31/12/23 |
31/12/23 |
ASX - By Stock
|
5
|
2.7K
|
2
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
the Zig
|
3.5K |
1.0M |
2 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
2
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
the Zig
|
3.5K |
1.0M |
0 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
0
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
the Zig
|
3.5K |
1.0M |
8 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
8
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
the Zig
|
1.0K |
315K |
5 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
1.0K
|
315K
|
5
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
the Zig
|
1.0K |
315K |
2 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
1.0K
|
315K
|
2
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
the Zig
|
3.5K |
1.0M |
5 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
5
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
the Zig
|
3.5K |
1.0M |
5 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive new DMD Combination Therapy Data in mdx mice
|
|
the Zig
|
66 |
19K |
0 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
66
|
19K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive new DMD Combination Therapy Data in mdx mice
|
|
the Zig
|
66 |
19K |
1 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
66
|
19K
|
1
|
|
ASX - By Stock
|
PER |
Re:
News: ANP Antisense Therapeutics Announces Intention To Launch Share Purchase Plan
|
|
the Zig
|
1 |
373 |
0 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
1
|
373
|
0
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
the Zig
|
1.0K |
315K |
0 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
1.0K
|
315K
|
0
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
the Zig
|
1.0K |
315K |
1 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
1.0K
|
315K
|
1
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
the Zig
|
1.0K |
315K |
3 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
1.0K
|
315K
|
3
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
the Zig
|
1.0K |
315K |
6 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
1.0K
|
315K
|
6
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
the Zig
|
3.5K |
1.0M |
1 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
the Zig
|
3.5K |
1.0M |
2 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK
|
|
the Zig
|
29 |
8.8K |
2 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
29
|
8.8K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK
|
|
the Zig
|
29 |
8.8K |
1 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
29
|
8.8K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK
|
|
the Zig
|
29 |
8.8K |
18 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
29
|
8.8K
|
18
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
the Zig
|
3.5K |
1.0M |
0 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Shareholder Newsletter
|
|
the Zig
|
98 |
30K |
4 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
98
|
30K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Shareholder Newsletter
|
|
the Zig
|
98 |
30K |
4 |
20/06/23 |
20/06/23 |
ASX - By Stock
|
98
|
30K
|
4
|
|
ASX - By Stock
|
BUB |
Re:
Ann: Bubs Australia - Board Letter to Shareholders
|
|
the Zig
|
20 |
12K |
3 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
20
|
12K
|
3
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
the Zig
|
3.5K |
1.0M |
1 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: First Patient Dosed in ATL1102 Phase IIb DMD Trial
|
|
the Zig
|
34 |
13K |
0 |
12/06/23 |
12/06/23 |
ASX - By Stock
|
34
|
13K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Shareholder Newsletter
|
|
the Zig
|
98 |
30K |
4 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
98
|
30K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Shareholder Newsletter
|
|
the Zig
|
98 |
30K |
21 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
98
|
30K
|
21
|
|
ASX - By Stock
|
PER |
Re:
Ann: Shareholder Newsletter
|
|
the Zig
|
98 |
30K |
6 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
98
|
30K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: Shareholder Newsletter
|
|
the Zig
|
98 |
30K |
0 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
98
|
30K
|
0
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
the Zig
|
3.5K |
1.0M |
2 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
2
|
|
ASX - By Stock
|
RGT |
Re:
What's going on?
|
|
the Zig
|
5 |
3.1K |
4 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
5
|
3.1K
|
4
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
the Zig
|
1.0K |
315K |
3 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
1.0K
|
315K
|
3
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
the Zig
|
3.5K |
1.0M |
1 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
the Zig
|
3.5K |
1.0M |
1 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
the Zig
|
3.5K |
1.0M |
3 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
3
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
the Zig
|
1.0K |
315K |
7 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
1.0K
|
315K
|
7
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
the Zig
|
1.0K |
315K |
5 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
1.0K
|
315K
|
5
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
the Zig
|
1.0K |
315K |
1 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
1.0K
|
315K
|
1
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
the Zig
|
1.0K |
315K |
6 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
1.0K
|
315K
|
6
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
the Zig
|
1.0K |
315K |
5 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
1.0K
|
315K
|
5
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
the Zig
|
1.0K |
315K |
8 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
1.0K
|
315K
|
8
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
the Zig
|
3.5K |
1.0M |
3 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
3
|
|
ASX - By Stock
|
PER |
Re:
Sarepta FDA Hearing
|
|
the Zig
|
99 |
29K |
2 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
99
|
29K
|
2
|
|